References
- Goetz K. L. Am. J. Physiol. 1988; 254: E1–E15
- Brands M. W., Freedman R. H. Am. J. Physiol. 1988; 254: R1011–R1016
- Garcia R., Cantin H., Genest J., Thibault G. Proc. Soc. Exp. Biol. Med. 1987; 185: 352–358
- Garcia R., Thibault G., Gutkowska J., Harky K., Hamet P., Catin M., Genest J. Proc. Soc. Exp. Biol. Med. 1985; 179: 396–401
- Janssen W. M.T., De Zeew D., Van der Hemm G. K, De Jong P. E. Hypertension 1989; 13: 640–646
- Riegger J A.J.G., Kromer E. P., Kochsiek K. J. Cardiovasc. Pharmacol. 1986; 8: 1107–1112
- Cody R. J., Atlas S. A., Laragh J. H., et al. J. Clin. Invest. 1986; 78: 1362–1374
- Connell J. M.C., Jardine A. G. Atrial Natriuretic Factor, A. D. Struthers. Blackwell Scientific, Oxford 1990; 181–194
- Maack T., Suzuki M., Almeide F. A., Nussenzveig G., Scarborough R. M., McEnroe G. A., et al. Science 1987; 238: 675–677
- Seymour A. A, Swerdel J. N., Fenwell S. A., Druckman S. P., Neubeck R., Delaney N. G. J. Cardiovasc. Pharmacol. 1989; 14: 194–204
- Sybertz E. J, Chin P. J.S., Vemulapalli S., Pittis B., Foster C. J., Watkins R. W., Barnett A., Haslanger M. F. J. Pharmacol. Exp. Ther. 1989; 250: 624–631
- Koepke J. P., Tyler L. D., Blehem D. J., Schul J. R., Blaine E. H. Hypertension 1990; 16: 642–647
- Northridge D., Jackson N., Metcalfe M. J., McFarlane N., Dargie H. Br. J. Clin. Pharmacol. 1991; 32: 645
- Northridge D., Me Muray J., Dargie H., Jackson N. Heart Failure ″95 1–4 April. Amsterdam 1995; 189, 1995
- Roques B. P., Noble F., Dauge V., Fournié-Zaluski M. C., Beaumont A. Farmacol. Reviews 1993; 45: 87–146
- Neustadt B. R. Current Drugs 1993; 1175–1180
- Sociéte Civile Bioproject European Patent Application. EP419,327, 27 March 1991
- Squibb & Sons. United States Patent 4,432,972, 21 February 1984
- Bertenshaw S. R., Rogers R. S., Stern M. K., Norman B. H., Moore W. M., Jerome G. M., Branson L. M., McDonald J. F., McMahon E. G., Palomo M. A. J. Med. Chem. 1993; 36: 173–176
- De Lombaert S., Blanchard L., Tan J., Sakane Y., Berry C., Ghai R. D. Bioorg. Med. Chem. Lett. 1995; 5: 145–150
- Danilewicz J. C., Barclay P. L., Barnish I. T., Brown D., Cambell S. F., James K., Samuels G. M.R., Terrett N. K., Wythes M. J. Biochem. Biophys. Res. Com. 1989; 164: 58–65
- Ksauder G. M., Diefenbacher C. G., Yuan A. M., Clark F., Sakane Y., Ghay R. D. J. Med. Chem. 1989; 32: 2519–2526
- Maeda T., Balakrishanan K., Mehedi S. Q. Biochim. Biophys. Ada 1983; 731: 115–120
- Llorens C., Schwartz J. C. Eur. J. Pharmacol 1981; 69: 113–118
- Holmquist B., Bunning P., Riordan J. F. Anal. Biochem. 1979; 95: 540–548
- Ferrari G., Marcon E. Farmaco Ed. Scient 1958; 485–499, The heterocycles aminoacids were prepared as described in:(methyl 2-amino-isonicotinate
- Hale W. J., Hoyt W. J. Am. Chem. Soc. 1915; 37: 2538–2552, 2-amino-4-thiazolylacetic acid was a commercial sample. Ethyl 4-aminopyrrole; 2-carboxylate
- Roques-Fournie B. P., Zalusky M. C., Soroco E., Leconte J. M., Malfroy B., Lorens L C., Scharwz J. C. Nature (Land) 1980; 288: 286–288
- Roques B. P., Fournie-Zalusky M. C., Florentin D., Waksman G., Sassi A., Chaillet P., Collado H., Constein J. Life Sci. 1982; 31: 1479–1752
- De Lombaert S., Erion M. D., Tan J., Blanchard L., El-Chehab L., Ghai R. D., Sakane Y., Barry C., Trapani A. J. J. Med. Chem. 1994; 37: 498–511